Utility of tryptase genotyping in the screening, diagnosis, and management of systemic mastocytosis
Tryptase genotyping has an expanding role in the screening, diagnosis, and management of patients with systemic mastocytosis (SM). Reference ranges for basal serum tryptase (BST) based on increased TPSAB1 gene copy number can guide whether a patient's BST value is normal according to their spec...
Saved in:
| Main Authors: | Jeremy C. McMurray, Brandon J. Schornack, Joaquin Villar, Tracy I. George, Nathan A. Boggs |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Allergy |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/falgy.2025.1599358/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Defining “Normal” basal serum tryptase levels: a context-dependent approach to improve diagnostics in systemic mastocytosis
by: Francesca Crupi, et al.
Published: (2025-05-01) -
Assessment of skin manifestations under mastocytosis in adults and their associations with symptoms, level of tryptase and subtype of the disease
by: N. P. Teplyuk, et al.
Published: (2021-06-01) -
Hereditary alpha-tryptasemia and monoclonal mast cell disorders
by: Yannick Chantran, et al.
Published: (2025-06-01) -
Tryptase in children in the practice of an allergist
by: D. Sh. Macharadze
Published: (2023-03-01) -
Fire ant-venom anaphylaxis prevalence in the general population and patients with systemic mastocytosis
by: Jeremy C. McMurray, et al.
Published: (2025-03-01)